Health Condition 1: K740- Hepatic fibrosis
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Dr Radhika Mathiyazhagan
Dr Gaurav Sindwani
Eligibility
Inclusion criteria
Inclusion criteria: All adult chronic liver disease patients who had undergone LDLT between Jan 2017 and Dec 2019 at the Institute of Liver and Biliary Sciences.
Exclusion criteria
Exclusion criteria: Paediatric patients, Acute liver failure patients, Acute on chronic liver failure patients, Patients with moderate to severe HPS, preoperative severe restrictive/ obstructive lung diseases, Patients who had postoperative transfusion of blood and blood products within 48 hours of surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To find the correlation between the amount of intraoperative packed red blood cells, fresh frozen plasma, cryoprecipitate, platelets transfusion and postoperative pulmonary complications after living donor liver transplantation.Timepoint: 48 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of extubationTimepoint: 14 days;To find the correlation between the amount of intraoperative transfusion of FFP, platelets, cryoprecipitate and postoperative acute kidney injury after living donor liver transplantation.Timepoint: 48 hours;To find the correlation between the amount of intraoperative transfusion of FFP, platelets, cryoprecipitate with length of ICU and hospital stay.Timepoint: 60 days;To find the correlation between the amount of intraoperative transfusion of FFP, platelets, cryoprecipitate with the incidence of portal venous thrombosis(PVT) and hepatic artery thrombosis (HAT) .Timepoint: 7 days | — |
Countries
India
Contacts
Public ContactDr Gaurav Sindwani
Institute of Liver and Biliary Sciences
Outcome results
None listed